METHOTREXATE SODIUM (METHOTREXATE SODIUM) — FDA Approval ANDA089263 (ABRAXIS PHARM)
METHOTREXATE SODIUM (METHOTREXATE SODIUM) — FDA Approval ANDA089263 (ABRAXIS PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: METHOTREXATE SODIUM; Active ingredients: METHOTREXATE SODIUM; Application number: ANDA089263.
| Brand name | METHOTREXATE SODIUM |
|---|---|
| Active ingredients | METHOTREXATE SODIUM |
| Application number | ANDA089263 |
| Sponsor | ABRAXIS PHARM |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19860613 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →